Medicine Man Technologies (OTC: MDCL) $170 Million Cannabis Powerhouse – Update on Acquisitions & More.

Andy Williams

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Andy Williams

 

 

 

 

 

Medicine Man Technologies, Inc. (OTC: MDCL) CEO Interview with Andy Williams. NEXT SUPER STOCK conference presenter, Andy Williams delivers an update on MDCL’s transformation into a  vertically integrated cannabis powerhouse generating $170 million. Topics discussed, include:

  • Updates on pending acquisition status, now going through regulatory approval, and on track to close Q1 2020. 
  • Post-acquisition integration synergies to increase revenues and EBITDA. 
  • Cannabis market supply and pricing in Colorado versus other regions. 
  • Advantages of Colorado’s $1.7 billion regulated cannabis market versus California.
  • Impact of cannabis home delivery services in Colorado, which start in 2020.
  • Opportunities for MedPharm Holdings (pending acquisition), one of the few Federally-licensed growers of medical cannabis, and it’s R&D program which expects to launch clinical trials in 2020 for cannabis-based treatments for Alzheimers and dementia.